Computed tomography and magnetic resonance imaging approaches to Graves' ophthalmopathy: a narrative review

Front Endocrinol (Lausanne). 2024 Jan 8:14:1277961. doi: 10.3389/fendo.2023.1277961. eCollection 2023.

Abstract

Graves' ophthalmopathy (GO) affects up to 50% of patients with Graves' disease (GD) ranging from mild ocular irritation to vision loss. The initial diagnosis is based on clinical findings and laboratory tests. Orbital imaging, such as magnetic resonance imaging (MRI) and computed tomography (CT), is an important tool to assess orbital changes, being also useful for understanding disease progression and surgical planning. In this narrative review, we included 92 studies published from 1979 to 2020 that used either MRI and/or CT to diagnose and investigate GO, proposing new methods and techniques. Most of the methods used still need to be corroborated and validated, and, despite the different methods and approaches for thyroid eye disease (TED) evaluation, there is still a lack of standardization of measurements and outcome reports; therefore, additional studies should be performed to include these methods in clinical practice, facilitating the diagnosis and approach for the treatment of TED.

Keywords: Graves’ disease; Graves’ ophthalmopathy; computed tomography; imaging analysis; magnetic resonance imaging.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Eye
  • Graves Disease*
  • Graves Ophthalmopathy* / diagnostic imaging
  • Humans
  • Magnetic Resonance Imaging
  • Tomography, X-Ray Computed

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. We would like to thank to Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for funding this study under the process CAPES (AUXPE) 88881.859210/2023-01 and make it possible to be published.